Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CANF
CANF News & Events
-
Add to Watchlist
Trade CANF Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CANF News
Can-Fite Secures Japanese Patent Enhancing Market Position
9h ago
Newsfilter
Can-Fite Secures Japanese Patent for Obesity Treatment
6h ago
stocktwits
Can-Fite BioPharma to Attend BIO International Convention
Jun 17 2026
Newsfilter
Can-Fite BioPharma Publishes Canine Osteoarthritis Study Results
May 18 2026
Newsfilter
Can-Fite BioPharma Reports Positive Clinical Data for Namodenoson
Apr 30 2026
Newsfilter
Can-Fite Signs Up to $325M Deal with Vetbiolix
Mar 30 2026
Newsfilter
Can-Fite Biopharma Reports FY 2025 Financial Results
Mar 26 2026
seekingalpha
Can-Fite BioPharma Reports 2025 Financial Results and Clinical Advances
Mar 26 2026
Newsfilter
Show More News
CANF Events
No data
CANF Monitor News
Can-Fite Secures Japanese Patent for Namodenoson, Boosting Market Position
Jun 26 2026
Can Fite Biopharma Surges After Crossing Above 5-Day SMA
May 07 2026
Can-Fite BioPharma Reports Positive Clinical Data for Namodenoson
May 04 2026
Can-Fite Biopharma Reports Positive Clinical Data for Namodenoson
May 01 2026
Can Fite Biopharma shares surge amid market gains
Apr 30 2026
Can-Fite BioPharma Completes Financing Agreement and Drug Trial Success
Mar 05 2026
Can Fite Biopharma reaches 20-day high amid market gains
Mar 04 2026
Can Fite Biopharma surges on pre-market trading
Feb 05 2026
Show More Monitor News
CANF Earnings Analysis
No Data
People Also Watch
